Delivery Order SPE2DB20D2104-SPE2DB25F1263
Award Date
11/1/24
Potential Completion Date
11/4/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,270.29, is for the delivery of 90-count tablets of the medication Letrozole 2.5 mg. The contract has an ultimate completion date of May 5, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This delivery order is part of a...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,363.91 firm-fixed-price contract is for the delivery of 90 tablets of the medication Letrozole 2.5 mg. The contract has a completion date of May 28, 2025 and is not set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,993.56 firm fixed price delivery order is for the supply of Letrozole 2.5 mg tablets. The contract has an ultimate completion date of October 11, 2024 and was awarded on October 10, 2024. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Letrozole 2.5 mg tablets. The contract has a ceiling value of $1,073.72 and a period of performance through May 22, 2025. Amerisourcebergen Drug Corp is registered in the System for Award Management (SAM) and is classified as a for-profit organization. This delivery order is not set aside and is part of a larger Indefinite...
This federal contract award, valued at $2,318.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order to supply 4566490525 - Letrozole 2.5 mg Tablets in 90-count packages. The award has an Ultimate Completion Date of November 20, 2024 and a Firm Fixed Price pricing type. This contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 90 tablets of the drug Letrozole 2.5 mg. The contract has a ceiling value of $2,639.34 and a completion date of June 9, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed price and a ceiling value of $4,908.84. The contract is for the delivery of LETROZOLE 2.5 MG TABLET 90S, a pharmaceutical product, with a period of performance through May 23, 2025. The contract is not set aside for any special designation. Amerisourcebergen Drug Corp...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,553.66 firm-fixed-price delivery order contract is for the provision of Letrozole 2.5 mg tablets. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical to supply a wide range of pharmaceutical products and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Letrozole 2.5 mg tablets, with a ceiling value of $2,774.22 and a period of performance running through February 18, 2025. The contract is a firm-fixed-price delivery order that does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LETROZOLE 2.5 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $1,243.32. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 19, 2025. The contract is not set aside and was awarded on May 16, 2025....